“lymphoma” Archives

Entry Author Date Location
Pioneer’s Lament: Lack of Checkpoint Immunotherapy For Blood Cancer 12/08/14 National
TX Roundup: Need, Experiment Engine, Bigcommerce, Bellicum, CS Disco 12/02/14 Texas
Houston Biotech Firm Bellicum Pharmaceuticals Files for IPO 11/19/14 Texas
Houston’s Bellicum Nets $55M to Boost Trials for Cancer Treatment 08/27/14 Texas
Isis Execs Upbeat as AstraZeneca Expands Cancer Drug Collaboration 06/05/13 San Diego
Onyx, Millennium, Ariad: Firms to Watch at Hematology Meeting 12/07/12 Boston
Cell Therapeutics Pulls FDA Application, Saying It Isn’t Ready For Panel 01/30/12 Seattle
Celgene Buys Avila for $350M, Gaining Promising “Covalent” Drugs 01/26/12 Boston
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
San Diego’s Polaris Moves to Late-Stage Test of Drug for Liver Cancer and Other “Arginine-Dependant” Tumors 04/27/11 San Diego
HemaQuest Pockets Full $12M to Treat Sickle Cell and Other Blood Disorders 04/21/10 Seattle
Paul Allen Diagnosed with Cancer 11/16/09 Seattle
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News 10/08/09 Seattle
Seattle Genetics Shares Drop on Halted Lymphoma Trial 10/05/09 Seattle
Genzyme’s Mozobil Gets European Approval 08/05/09 Boston
Fate Therapeutics Starts First Clinical Trial of Drug to Boost Stem Cell Transplants 05/27/09 San Diego
Riding a Cancer Diagnostics Wave, Genoptix Sees Boom Continuing in 2009 04/01/09 San Diego
Cell Therapeutics Reports Severe Cardiac Events in Drug Trial 03/16/09 Seattle
Seattle Genetics Gets Orphan Drug Status 01/26/09 Seattle
Genzyme Wins FDA Approval of Mozobil 12/15/08 Boston
Blood News: A Quick Rundown of Headlines From the American Society of Hematology 12/09/08 National
Gloucester Drug Shrinks Tumors in Lymphoma Study 12/08/08 Boston
Seattle Genetics “Empowered Antibody” Shines at Blood Disease Meeting 12/06/08 Seattle
Zevalin Gets 6-Month FDA Review 12/01/08 Seattle
Cell Therapeutics, Spectrum Form Joint Venture 11/26/08 Seattle
Cell Therapeutics Lymphoma Drug Wipes Out Tumors in Pivotal Trial 11/11/08 Seattle
Cell Therapeutics, Still Fighting, Gets Zevalin Data Published In Cancer Journal 10/16/08 Seattle
Cell Therapeutics To File for FDA Approval of Zevalin In First-Line Lymphoma 09/22/08 Seattle
Biogen Idec Isn’t Sweating Possible Sale of Genentech to Roche 07/22/08 Boston
Page 2 of 2 « previous page